A useful approach to total analysis of RISC-associated RNA
© Hayashida et al; licensee BioMed Central Ltd. 2009
Received: 14 July 2009
Accepted: 26 August 2009
Published: 26 August 2009
Identifying the endogenous RNA induced silencing complex(RISC)-associated RNAs is essential for understanding the cellular regulatory networks by miRNAs. Recently, isolation of RISC-associated mRNAs using antibody was reported, but their method needs a large amount of initial materials. We tried to improve the protocol and constructed an efficient and convenient system for analyzing miRNA and mRNA contents in RISC.
With our protocol, it is possible to clone both miRNAs and mRNAs from the endogenous RISC-associated RNAs immunoprecipitated from less than 107 cells, and we show the ability of our system to isolate the particular target mRNAs for a specific miRNA from the RISC-associated mRNAs using well-characterized miR-122 as an example. After introduction of miR-122 into HepG2 cells, we found several cDNA clones that have miR-122 target sequences. Four of these clones that were concentrated in RISC but decreased in total RNA fraction are expected to be miR-122 target candidates. Interestingly, we found substantial amounts of Alu-related sequences, including both free Alu RNA and Alu-embedded mRNA, which might be one of the general targets for miRNA, in the cDNA clones from the RISC-associated mRNAs.
Our method thus enables us to examine not only dynamic changes in miRNA and mRNA contents in RISC but also the relationship of miRNA and target mRNA. We believe that our method can contribute to understanding cellular regulatory networks by miRNAs.
MicroRNAs (miRNAs) are approximately 22-nucleotide endogenous non-coding RNAs that play important roles in post-transcriptional regulation of gene expression by base-pairing to their target mRNAs . After being transcribed and processed, mature miRNAs are incorporated into the Argonaute protein family, the core component of the RNA-induced silencing complex (RISC), for targeting mRNAs based on sequence complementation in 3'UTRs [2–4]. In humans, the Argonaute family consists of eight members, divided into the Ago subfamily (Ago1-Ago4) and Piwi subfamily (PIWIL1-PIWIL4) . Although all four Ago subfamily members have been implicated in translational inhibition of mRNA , only one Ago protein, Ago2, possesses intrinsic endonuclease activity. Experiments in mice and human cell lines have shown that Ago2 is the central RISC component, capable of cleaving target mRNA when perfect complementarity with it exists [7–12].
Identifying the target mRNA against miRNA is essential to understand cellular regulatory networks by miRNAs. Due to the low complementarity between a miRNA and its target mRNAs, only a few mammalian target mRNAs have been identified. Combinations of biochemical and computational approaches have been started to elucidate how mRNA targets are specifically recognized by miRNAs. Among biochemical approaches, recovery of miRNA from RISC using antibody [13–16] has already been reported, and recently that of RISC-associated mRNA from the immunoprecipitates was also reported [17–21]. However, isolation of RISC-associated mRNA has mainly been performed using exogenously introduced Tagged-Ago2 or GW182 in combination with antibodies to the Tag [18–21], and the protocol needs improvement for the efficient analysis of the RISC-associated mRNA without using large amounts of initial materials .
Cell culture and transfection
HeLa, HEK293, and HepG2 cells were grown in DMEM supplemented with 10% fetal calf serum. THP-1 and P388D1 cells were grown in RPMI1640 supplemented with 10% fetal calf serum. Transfection of HepG2 cells was performed using Lipofectamine RNAi max reagent (Invitrogen). A total of 5 × 106 cultured cells were transfected with 600 pmol miR-122 siRNA (5'-UGGAGUGUGACAAUGGUGUUUGU-3', 5'-AAACACCAUUGUCACACUCCAUA-3') or control siRNA firefly luciferase GL3 (Nippon Gene) according to the manufacturer's instructions. After 24 hours, transfected cells were collected.
Immunoprecipitation and RNA purification
Cultured cells (5 × 106~1 × 107 cells) were collected by trypsinization and washed with PBS(-). Cells were incubated in 1 ml of lysis buffer (20 mM Tris pH7.4, 2.5 mM MgCl2, 200 mM NaCl, 0.05% NP40) for 10 min on ice, and the cell lysates were cleared by centrifugation at 20000 ×g for 20 min at 4°C. Twenty μl of ProteinG coupling beads (Dynal) bound with 5 μg of anti-human Ago2 antibody 4G8 (Wako) was added to cell lysate and mixed by rotation for 2 hours at 4°C. The beads were then washed three times with 1 ml lysis buffer, and bound Ago2-RNA complex were eluted with 0.5% SDS solution. Eluted complex was extracted with phenol/chloroform, and the RNA was precipitated with ethanol.
Total RNA from cultured cells was extracted using ISOGEN (Nippon Gene). A small RNA fraction (< 200 nt) was obtained using the mir Vana™ miRNA Isolation Kit (Ambion). Small RNA 20–24 nt long was purified from the small RNA fraction by denatured 15% polyacrylamide gel electrophoresis, treated with phenol/chloroform/isoamyl alcohol (25:24:1), and ethanol-precipitated.
Gel electrophoresis of immunoprecipitates
The immunoprecipitate from 5 × 106 cells was loaded onto 10–20% SDS-polyacrylamide gel. After electrophoresis, the protein was stained with a Wako Silver staining kit (Wako). Western blot examination was performed using anti-human Ago2 antibody 4G8.
The immunopurified RNA derived from 5 × 106 cells was loaded onto 10% polyacrylamide TBE-Urea gel and run in 0.5 × TBE at 10 mA for 50 min. After electrophoresis, the gel was silver stained with Clear stain Ag (Nippon Gene) to check amounts of small RNA.
cDNA cloning of small RNA
The RNA was dephosphorylated with 1 unit of shrimp alkaline phosphatase (USB) for 30 min at 37°C in 50 mM Hepes (pH7.3), 5 mM MgCl2, and 10 mM KCl. Then a 5' phosphate and 3' dideoxy modified 3' RNA adaptor (5'-prArArGrArArGrCUrGrGrCrGUrCrArAUrGUddC-3') was ligated with 10 units of ThermoPhage™ single-stranded DNA ligase (PROKARIA) for 30 min at 60°C in 25 mM Hepes (pH7.3), 2.5 mM MgCl2, 5 mM KCl, 0.05 mM ATP, 1 mM dithiothreitol (DTT), 25 ng/μl BSA. The reaction liquid was treated with phenol/chloroform/isoamyl alcohol, and ethanol-precipitated. The 3' adaptor ligated RNA and 2.5 μM of a first-strand primer (5'-GACATTGACGCCAGCTTCTT-3') with sequence complementary to the ligated 3' RNA adaptor were mixed and the cDNA was synthesized with 200 units of ReveScript IV reverse transcriptase (Wako) for 30 min at 42°C in the manufacturer's 1 × reaction buffer (50 mM Tris-HCl, pH8.3, 75 mM KCl, 3 mM MgCl2, 5 mM DTT, 2 mM dNTPs with 20 units of Ribonuclease Inhibitor, Super (Wako)). The mixture was incubated for 30 min at 65°C in 167 mM EDTA and 53 mM NaOH to hydrolyze the RNA template. Then the hydrolyzed reaction mixture was neutralized with 20 mM Tris-HCl, pH 7.5 and treated with phenol/chloroform/isoamyl alcohol, and ethanol-precipitated. The remaining single-stranded cDNA was dephosphorylated with shrimp alkaline phosphatase and ligated to the 5' phosphated and 3' dideoxy modified 5' adaptor (5'-pAAGGCTCAGTCTCGGGATAddC-3') with ThermoPhage™ single-stranded DNA ligase. The ligated cDNA was amplified by 2-step PCR with 2.5 units of HotGoldstar™ DNA polymerase (Eurogentec) in the manufacturer's 1 × reaction buffer with 0.25 mM dNTPs, 5 μM of 5' PCR primer (5'-GTATCCCGAGACTGAGCC-3'), and 5 μM of 3' PCR primer (5'-GACATTGACGCCAGCTTC-3') corresponding to 5' adaptor and 3' adaptor sequence, respectively. The reaction was performed at 95°C for 10 min, 95°C for 20 sec, 56°C for 10 sec, and 72°C for 10 sec for 15 cycles, and 7(EtBr) staining. The purified PCR product was amplified by a second PCR with the 2°C for 1 min. After the first 15 cycles, products were loaded on a 15% native polyacrylamide gel electrophoresis and 60–64 bp fragments were excised after ethidium bromide same conditions as the first PCR, and the product was purified by gel electrophoresis. The product was ligated to 20 ng of pGEM T Easy Vector (Promega) with a DNA Ligation Kit Mighty Mix (Takara Bio) and transfected into DH5α. Plasmid DNA was prepared with the QuickGene Plasmid Kit S (FUJIFILM) and sequenced with the BigDye® Terminator Cycle Sequencing Kit (Applied Biosystems). Each miRNA was identified using the BLAST homology search program http://blast.ddbj.nig.ac.jp/top-j.html.
cDNA cloning of anti-Ago2- immunoprecipitated mRNA
The first-strand cDNA was synthesized with 200 units of ReveScript IV reverse transcriptase for 10 min at 42°C in the manufacturer's buffer (50 mM Tris-HCl, pH8.3, 75 mM KCl, 3 mM MgCl2, 5 mM DTT, 2 mM dNTPs with 20 units of Ribonuclease Inhibitor, Super) using oligo-dT(20) primer (5'-GACCATATGACGAGATCCGAGCTTCTTTTTTTTTTTTTTTTTTTT-3') with the sequence for PCR amplification. Then the mixture was incubated for 30 min at 65°C in 167 mM EDTA and 53 mM NaOH to hydrolyze RNA template. The hydrolyzed mixture was neutralized with 20 mM Tris-HCl, pH 7.5 and purified with the Invisorb® Spin PCRapid Kit (Invitek). Then the second-strand cDNA was synthesized using 4 μM random primers (5'-CATGGTATCGACGAGACTGAGGCTGNNNNNNNNNB-3', N = A, C, G, T, B = C, G, T) containing the sequence for subsequent PCR amplification with 2.5 units of HotGoldstar™ DNA polymerase in the manufacturer's reaction buffer with 0.2 mM dNTPs. The reaction was performed at 95°C for 10 min, 30°C for 1 min, 40°C for 30 sec, 50°C for 30 sec, 60°C for 30 sec, 72°C for 2 min, and 95°C for 1 min, followed by chilling on ice for 1 min, and cDNA was then purified with the Invisorb® Spin PCRapid Kit. The double-stranded cDNA was amplified by PCR with 2.5 units of HotGoldstar™ DNA polymerase in the manufacturer's reaction buffer with 0.2 mM dNTPs and 4 μM each of the 5' PCR primer (5'-CATGGTATCGACGAGACTGAG-3') and 3' PCR primer (5'-GACCATATGACGAGATCCGAG-3'). The reaction was performed at 95°C for 10 min, 95°C for 20 sec, 60°C for 10 sec, and 72°C for 30 sec for 24 cycles, and 72°C for 2 min. The amplified cDNA was purified with the Invisorb® Spin PCRapid Kit. The size distribution of the cDNA was analyzed with the Bioanalyzer DNA 1000 Kit (Agilent Technologies). The residue of purified PCR product was ligated to 20 ng of pGEM T Easy Vector with DNA Ligation Kit Mighty Mix for 1 h at 16°C to construct a cDNA library and transformed into DH5α. Plasmid DNA was prepared with the QuickGene Plasmid Kit S and sequenced with the BigDye® Terminator Cycle Sequencing Kit. The identification of mRNA species corresponding to each cDNA sequence was performed using the BLAST homology search program. To detect microRNA target sites in isolated mRNA, the microRNA target prediction search program TargetScan 4.2 http://www.targetscan.org/index.html was used. In addition, mRNA expression data for cells and tissues were searched using the microarray database RefExA http://www.lsbm.org/. Free Alu RNA or Alu RNA embedded mRNA was predicted by a homology search against three types of human primary Alu transcript (GeneBank accession Nos. U67811, U67812, and U67813) using GENETYX® (GENETYX) gene analysis software, and molecules with greater than 60% homology were classified as Alu RNA-related. 'Hit in genome' demonstrates the sequences that were not categorized by BLAST search.
Reverse transcription of mRNA was performed using the SuperScript VILO cDNA Synthesis Kit (Invitrogen) following the manufacturer's instructions. Immunopurified RNA (derived from all transfected cells) and 1 μg of total RNA were used for reverse transcription. Quantitative-PCR of mRNA was performed using gene specific primer pairs and 2 × Power SYBR Master Mix (Applied Biosystems) following the manufacturer's instructions. Quantitative-PCR were performed on the ABI 7500 real-time PCR system.
Results and Discussion
Isolation of endogenous Ago2 and miRNA complex
For the immunoprecipitation of Ago2 protein, we used an anti-human Ago2 antibody 4G8, which has been described for its immunoprecipitating activity and specificity [13, 22]. SDS-PAGE analysis of the immunoprecipitates from human cell line extracts of HeLa, HepG2, HEK293 and THP-1 but not of mouse cell line P388D1 yielded a clear Ago2 protein band of approximately 100 kDa. Also, PAGE analysis revealed a highly purified RNA band of approximately 22 nucleotides long in the immunoprecipitates of all human cell lines tested (Additional file 1). In addition, we also ascertained this procedure can be applicable to the tissue extract. To profile the immunopurified RNA, we performed a microarray analysis using the μParaflo® microfluidics chip (LC Sciences) with a complementary sequence of human 474 miRNAs on it (miRBase release 9.0) and compared the profile with that of total RNA. The miRNA profile of HeLa cell immunopurified RNA exhibited almost the same pattern with that of total RNA (Additional file 2) suggesting that Ago2-immunopurification could trap almost all expressed miRNA species.
Construction of a simple and efficient method for cloning of miRNA
Cloning of antibody-isolated mRNA
Since a significant amount of mRNA is known to be immunoprecipitated with RISC-associated RNA, we developed a cloning system for the trapped mRNA. Because the mRNA content in the immunoprecipitates from 107 cells was small and varied in size, we included a PCR amplification step in the cloning of immunoprecipitated mRNAs. To avoid PCR-derived bias due to the variation in the length of mRNA for cloning efficiency, we did not aim to synthesize the full-length cDNA and used random primers for the second-strand cDNA synthesis (Additional file 3). The human mRNA database is now almost completed and the sequence information of 3' short cDNA fragments is sufficient to identify each mRNA species. Independence of the length and terminal cap structure of template RNA may be suitable for comprehensive profiling of mRNAs. We tested the cloning efficiency of three mRNA species with different lengths (albumin: 2122b, beta-actin: 1874b, GAPDH: 1380b). We mixed them in equal amounts and confirmed nearly equal ratios of cloning for these input mRNAs (15, 19, and 14 clones from total 48 clones, respectively). With this protocol, cDNA cloning of immunoprecipitated mRNA could be achieved with relatively small amount of RNA prepared from 1 × 107 cells.
We picked 91 clones and analyzed their sequences. The profile of the cDNA clones deduced by BLAST search is shown in Figure 2B, and all isolated mRNA clones are listed in Additional file 4. Of the 91 clones, 79 clones (86.8%) were identified as mRNA, and the average length of inserted cDNA in the 91 clones was calculated to be 244.8 bp including a poly(A) tail of 31.5 bp. In the course of this analysis, we noticed that the cloned cDNAs contained a relatively high percentage of Alu-related sequences. Of the mRNA clones, about 16.5% (13/79 clones) of clones harbored an Alu sequence in the 5'- or 3'-UTR sequences, whereas the percentage of Alu-containing mRNA in human mRNA species is reported to be about 5% . Alu elements can be transcribed in two different fashions, yielding 'free Alu RNAs', which are transcribed from their own promoter, and 'embedded Alu RNAs', which are transcribed as a part of coding RNAs . Based on the results from in silico analysis, it was speculated that Alu RNAs embedded in 3'-UTRs are probable miRNA targets . Our findings may be the first to show that mRNA with Alu sequences are concentrated in RISC-associated mRNA, and suggest the regulation of gene expression by miRNA through these sequences. A substantial number of free Alu RNAs (4 clones) was also found in the cDNA prepared from HeLa cell extract (Figure 2B). These free Alu RNA clones exhibited a high degree of homology with each other, though none had the same sequence (Additional file 5). In contrast, no cDNA clone in the control IgG experiment has Alu sequence. In the case of HepG2 cells (described in the later section), about 10% of total cDNA from Ago2-immunoprecipitated mRNA were clones with the free Alu RNA sequence. These data suggest the possible binding of free Alu RNAs to some sort of miRNA.
Changes in RISC-associated mRNA after miR-122 introduction into HepG2 cells
(i) Changes in Alu RNA and mitochondrial mRNA in RISC
The compositions of cDNA isolated from Ago2-associated miR-122- or GL3-transfected HepG2 cells are shown in Figure 3B. Whereas the percentage of free Alu RNA remained constant at about 10% of cDNA, that of Alu-embedded mRNA decreased significantly after miR-122 transfection. These findings may have been obtained because Alu-embedded mRNA does not have target sequences against miR-122 . From the miR-122-transfected cells, substantial amounts of mitochondrial mRNA were cDNA-cloned and almost all of which was COX3 (cytochrome c oxidase subunit 3) mRNA. However, since mitochondrial mRNAs are retained inside of the mitochondria in cells, these findings must be artifactual. Since COX3 mRNA has two miR-122 target sites, we speculate that during cell lysis, abundant mitochondrial mRNA leaks from the broken mitochondria and reacts with the miR-122.
(ii) Possible approach to screening of miR-122 target mRNA
Eventhough the number of clones we examined was very limited and comprised only a portion of libraries we obtained, several miR-122 target candidates could be picked up. We believe that these results show the potential of our protocol for isolating the miRNA targets.
We thank Mikiko C Siomi and Haruhiko Siomi (Keio University) for helpful comments. We also thank Ryo Ukegawa, Masaki Warashina, Mari Mitsuba, Makoto Amano, and Tomonori Matsuda for technical assistance and advice.
- Bartel DP: MicroRNA:genomics, biogenesis, mechanism, and function. Cell. 2004, 116: 281-297. 10.1016/S0092-8674(04)00045-5.View ArticlePubMedGoogle Scholar
- Hammond SM, Bernstein E, Beach D, Hannon GJ: An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature. 2000, 404: 293-296. 10.1038/35005107.View ArticlePubMedGoogle Scholar
- Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ: Argonaute2, a link between genetic and biochemical analyses of RNAi. Science. 2001, 293: 1146-1150. 10.1126/science.1064023.View ArticlePubMedGoogle Scholar
- Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R: Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell. 2005, 123: 631-640. 10.1016/j.cell.2005.10.022.View ArticlePubMedGoogle Scholar
- Sasaki T, Shiohama A, Minoshima S, Shimizu N: Identification of eight members of the Argonaute family in the human genome. Genomics. 2003, 82: 323-330. 10.1016/S0888-7543(03)00129-0.View ArticlePubMedGoogle Scholar
- Pillai RS, Artus CG, Filipowicz W: Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis. RNA. 2004, 10: 1518-1525. 10.1261/rna.7131604.PubMed CentralView ArticlePubMedGoogle Scholar
- Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T: Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell. 2004, 15: 185-197. 10.1016/j.molcel.2004.07.007.View ArticlePubMedGoogle Scholar
- Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-Tor L, Hannon GJ: Argonaute2 is the catalytic engine of mammalian RNAi. Science. 2004, 305: 1437-1441. 10.1126/science.1102513.View ArticlePubMedGoogle Scholar
- Song JJ, Smith SK, Hannon GJ, Joshua-Tor L: Crystal structure of Argonaute and its implications for RISC slicer activity. Science. 2004, 305: 1434-1437. 10.1126/science.1102514.View ArticlePubMedGoogle Scholar
- Meister G, Tuschl T: Mechanisms of gene silencing by double-stranded RNA. Nature. 2004, 431: 343-349. 10.1038/nature02873.View ArticlePubMedGoogle Scholar
- Hutvagner G, Zamore PD: A microRNA in a multiple-turnover RNAi enzyme complex. Science. 2002, 297: 2056-2060. 10.1126/science.1073827.View ArticlePubMedGoogle Scholar
- Yekta S, Shih IH, Bartel DP: MicroRNA-directed cleavage of HOXB8 mRNA. Science. 2004, 304: 594-596. 10.1126/science.1097434.View ArticlePubMedGoogle Scholar
- Azuma-Mukai A, Oguri H, Mituyama T, Qian ZR, Asai K, Siomi H, Siomi MC: Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc Natl Acad Sci USA. 2008, 105: 7964-7969. 10.1073/pnas.0800334105.PubMed CentralView ArticlePubMedGoogle Scholar
- Rüdel S, Flatley A, Weinmann L, Kremmer E, Meister G: A multifunctional human Argonaute2-specific monoclonal antibody. RNA. 2008, 14: 1244-1253. 10.1261/rna.973808.PubMed CentralView ArticlePubMedGoogle Scholar
- Nelson PT, De Planell-Saguer M, Lamprinaki S, Kiriakidou M, Zhang P, O'Doherty U, Mourelatos Z: A novel monoclonal antibody against human Argonaute proteins reveals unexpected characteristics of miRNAs in human blood cells. RNA. 2007, 13: 1787-1792. 10.1261/rna.646007.PubMed CentralView ArticlePubMedGoogle Scholar
- Ikeda K, Satoh M, Pauley KM, Fritzler MJ, Reeves WH, Chan EK: Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody. J Immunol Methods. 2006, 317: 38-44. 10.1016/j.jim.2006.09.010.PubMed CentralView ArticlePubMedGoogle Scholar
- Beitzinger M, Peters L, Zhu JY, Kremmer E, Meister G: Identification of human microRNA targets from isolated Argonaute protein complexes. RNA Biol. 2007, 4: 76-84.View ArticlePubMedGoogle Scholar
- Karginov FV, Conaco C, Xuan Z, Schmidt BH, Parker JS, Mandel G, Hannon GJ: A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci USA. 2007, 104: 19291-19296. 10.1073/pnas.0709971104.PubMed CentralView ArticlePubMedGoogle Scholar
- Easow G, Teleman AA, Cohen SM: Isolation of microRNA targets by miRNP immunopurification. RNA. 2007, 13: 1198-1204. 10.1261/rna.563707.PubMed CentralView ArticlePubMedGoogle Scholar
- Hendrickson DG, Hogan DJ, Herschlag D, Ferrell JE, Brown PO: Systematic identification of mRNAs recruited to Argonaute2 by specific microRNAs and corresponding changes in transcript abundance. PloS ONE. 2008, 3: e2126-10.1371/journal.pone.0002126.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhang L, Ding L, Cheung TH, Dong MQ, Chen J, Sewell AK, Liu X, Yates JR, Han M: Systematic identification of C.elegance miRISC proteins, miRNAs, and mRNA targets by their interactions with GW182 proteins AIN-1 and AIN-2. Mol Cell. 2007, 28: 598-613. 10.1016/j.molcel.2007.09.014.PubMed CentralView ArticlePubMedGoogle Scholar
- Miyoshi K, Uejima H, Nagami-Okada T, Siomi H, Siomi MC: In vitro RNA cleavage assay for Argonaute-family proteins. Methods Mol Biol. 2008, 442: 29-43. full_text.View ArticlePubMedGoogle Scholar
- Blondal T, Thorisdottir A, Unnsteinsdottir U, Hjorleifsdottir S, Aevarsson A, Ernstsson S, Fridjonsson OH, Skirnisdottir S, Wheat JO, Hermannsdottir AG, Sigurdsson ST, Hreggvidsson GO, Smith AV, Kristjansson JK: Isolation and characterization of a thermostable RNA ligase 1 from a Thermus scotoductus bacteriophage TS2126 with good single-stranded DNA ligation properties. Nucleic Acid Res. 2005, 33: 135-142. 10.1093/nar/gki149.PubMed CentralView ArticlePubMedGoogle Scholar
- Mineno J, Okamoto S, Ando T, Sato M, Chono H, Izu H, Takayama M, Asada K, Mirochnitchenko O, Inouye M, Kato I: The expression profile of microRNAs in mouse embryos. Nucleic Acid Res. 2006, 34: 1765-1771. 10.1093/nar/gkl096.PubMed CentralView ArticlePubMedGoogle Scholar
- Yulug IG, Yulug A, Fisher EM: The frequency and position of Alu repeats in cDNAs, as determined by database searching. Genomics. 1995, 27: 544-548. 10.1006/geno.1995.1090.View ArticlePubMedGoogle Scholar
- Häsler J, Samuelsson T, Strub K: Useful 'junk': Alu RNAs in the human transcriptome. Cell Mol Life Sci. 2007, 64: 1793-800. 10.1007/s00018-007-7084-0.View ArticlePubMedGoogle Scholar
- Smalheiser NR, Torvik VI: Alu elements within human mRNAs are probable microRNA targets. Trends Genet. 2006, 22: 532-536. 10.1016/j.tig.2006.08.007.View ArticlePubMedGoogle Scholar
- Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, Negrini M: Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007, 67: 6092-6099. 10.1158/0008-5472.CAN-06-4607.View ArticlePubMedGoogle Scholar
- Fuchs BC, Bode BP: Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?. Semin Cancer Biol. 2005, 15: 254-266. 10.1016/j.semcancer.2005.04.005.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.